INTRODUCTION
The immunosuppressive peptide Cyclosporin A (CyA)c (Sandimmun® [1] ) is of special interest, because of its early use in the long-term treatment of autoimmune diseases and the prevention of allograft rejection after organ transplantation [1] [2] [3] . Its clinical a To whom all correspondence should be addressed: Prof. Dr administration requires cautious monitoring due to various side effects. In addition to nephrotoxicity, increased bilirubin plasma levels and elevated serum bile salt levels have been reported from animals and patients receiving the drug [4] [5] [6] [7] [8] [9] [10] , indicating cholestatic effects of CyA or its metabolites. In recent studies inhibition of bile salt biosynthesis was suggested as an explanation for the cholestatic effects seen at CyA treatment [11] . However, increased plasma levels of transaminases have not been reported [5, 6, 12, 13] , indicating a transport defect rather than a general cellular impairment. An interference of CyA with the transport of bile acids is discussed controversially. With isolated rat hepatocytes nonspecific binding of CyA to protein components of a postulated cholate transport system without uptake by this system was observed [14] , whereas competitive and noncompetitive inhibition of taurocholate uptake by CyA has been seen in membrane vesicle experiments [15, 16] .
To shed light on these controversies, a study was performed on the hepatic uptake and excretion of CyA using different experimental models such as liposomal phospholipid membranes, freshly isolated rat hepatocytes, and bile canalicular plasma membrane vesicles from rat liver.
MATERIALS AND METHODS

Chemicals
All cyclosporins were from Sandoz Pharma AG, Basle, Switzerland. [6-3H]-taurocholate (Na+-salt) with a specific activity of 6.6 Ci/mmol was obtained from DuPont-New England Nuclear (Dreieich, Germany). 22NaCl with a specific activity of 500 mCi/mg Na+ was purchased from Amersham (Buckinghamshire, UK). 1,6-diphenyl-1,3,5-hexatriene (DPH) was from Molecular Probes, Inc. (Eugene, OR). All other substances were obtained at the highest purity from commercial sources.
Isolation of hepatocytes
Isolated hepatocytes from livers of male Wistar rats were prepared by a modified collagenase perfusion technique [17] . The cells were suspended in Krebs-Henseleit-medium at a concentration of 2-3 x 106 cells/ml. They were allowed to recover for approximately 30 [18, 19] [20, 21] . Membrane vesicles were resuspended in the appropriate buffer media (see corresponding figure legends), and aliquots were stored frozen in liquid nitrogen until use. Transport measurements with bile canalicular plasma membrane vesicles Transport determinations in the presence and absence of ATP were determined by the rapid filtration assay following generally the recently described experimental protocols [22] . The exact initial compositions of the intravesicular buffers as well as of the extravesicular media are described in the respective figure legends. At the indicated time points, the uptake of radioactive substrate was stopped by addition of twice 2 ml ice-cold stop solution (50 mM sucrose, 100 mM KCl, 10 mM MgSO4, 10 mM Tris/HCl, pH 7.4). After an additional washing step, the vesicle-associated radioactivity on the filters was determined by liquid scintillation counting as described [22] . Photoaffinity labeling of bile canalicular membranes Membrane vesicles were resuspended in 50 mM sodium phosphate buffer, pH 7.4. Aliquots of 250 jl (-0.3-0.5 mg protein) were incubated with the sodium salt of 7,7 azo3a,12cz-dihydroxy-5B-[3B-3H]cholan-24-oyl)-2-aminoethanesulfonic acid or the photolabile CyA derivative (1 ,uM) for 3 min in the dark at 25°C. Photolysis was carried out at 300 or 350 nm for 5 min in a rotating cylindrical cuvette made of quartz glass in a Rayonet RPM 100 photoreactor (New England Ultraviolet, Hamden, Connecticut). The unbound radioactive derivatives were removed by centrifugation of the membrane suspension at 50,000 x g for 30 min. The membrane proteins were separated by SDS-polyacrylamide gel electrophoresis and the radioactivity incorporated into the various protein bands was determined as previously described [20] . Liposome preparation Liposomes for binding and fluorescence experiments were prepared by the extrusion technique, as described previously [23] . Dioleyl-phosphatidylcholine was used as phospholipid. The From that mixture, 28 pl aliquots were layered on the cooled microcolumns. The liposomes from the sample were directly eluted with 1 ml cold (0-4°C) iso-osmolar sucrose into a scintillation counting vial. Four ml of scintillation fluid were added and the radioactivity was measured for 60 min or until the relative standard deviation was less than 0.4 percent. As control experiment, 5 ml of the liposome-sucrose mixture was mixed with 1 ml of sucrose and the radioactivity was determined.
RESULTS
Cellular uptake studies The saturable uptake of taurocholate into freshly isolated hepatocytes was decreased in the presence of increasing concentrations of CyA in the incubation medium. The type of inhibition was apparently competitive (Figure 1 ). The transport of CyA isolated rat hepatocytes was determined in the concentration range from 0.1 uM to 10 gM. Higher concentrations resulted in visible precipitation of the cyclopeptide due to its highly lipophilic character. After a rapid concentration dependent absorption within the first 2 to 3 sec the uptake was linear over the whole time interval of investigation (up to 5 min). When the initial rates of uptake, derived from linear regression of the values for cell associated radioactivity between 15 sec and 60 sec, were plotted as a function of increasing concentrations, no marked deviation from linearity could be observed, indicating that the uptake occurs by passive diffusion (Figure 2) . The Cyclosporin-induced changes in physicochemical membrane properties The lipophilicity of CyA was determined by measuring the partition coefficient between liposomal membranes and buffer. The partition coefficient for CyA was 4034 ± 521 (mean ± SD, n = 20). In addition, liposomal membrane anisotropy was determined. In steady-state depolarization fluorescence studies, Dioleyl-phosphatidylcholine liposomes were incubated with increasing amounts of CyA in the concentration range between 0.5-10 ,uM. CyA caused a pronounced concentration-dependent decrease of anisotropy (Figure 3) , indicating a membrane-fluidizing effect (decrease of 46 percent measured at 25°C at a lipid:drug ratio of 13:1). Furthermore, Na+ and Ca2+_fluxes across liposomal membrane were determined. The permeability of liposomal membranes for Na+ and Ca2+ ions was dramatically increased in a dose-and time-dependent manner in the presence of CyA (Figure 4) , suggesting an ionophoric activity of the latter. Photoaffinity labeling studies with bile canalicular membrane vesicles Photoaffinity labeling of bile canalicular membrane vesicles from rat liver with a photolabile 3H-labelled CyA-derivative resulted in the incorporation of radioactivity into a polypeptide with apparent molecular weight of approximately 160,000 and in a minor labeling of polypeptides in the molecular weight range of 85,000-90,000 ( Figure Sa) . The extent of labeling of the polypeptide with the apparent molecular weight of 160,000 was reduced when the experiment was performed in the presence of unlabeled CyA or in the presence of PSC-833, a potent inhibitor of p-glycoprotein. Taurocholate (100 ,uM) had no effect on the extent of the labeling ( Figure Sa) . In contrast, when a photolabile bile salt derivative [Na+-salt of (7,7 azo-3a, 12a-dihydroxy-5B-[3B-3H]cholan-24-oyl)-2-aminoethanesulfonic acid] was used, the canalicular bile salt carrier protein with an apparent molecular weight of 110,000 was almost exclusively labeled. The extent of this labeling was only slightly reduced by 0.5 -5 FM CyA. A significantly lower extent of labeling was seen, when the experiment was performed in the presence of 100 jM taurocholate ( Figure Sb Kinetic studies were performed in order to support the photoaffinity labeling experiments and to clarify whether CyA only binds to membrane proteins or whether it is a transported substrate. When uptake of CyA was studied, the bile canalicular membrane vesicles showed an ATP-dependent transport (Figure 6 ), which could be inhibited by daunomycin, a p-glycoprotein substrate. Taurocholate had only minor effects upon CyA uptake rates in the vesicles. When the ATP-dependent transport of [3H]-taurocholate was determined, the presence of CyA resulted in a decrease of the maximum amount of bile salt accumulated in the vesicles with time. However, the initial rates of [3H]-taurocholate uptake within the first 2.5 min of determination remained unchanged at increasing CyA concentrations (Figure 7 ). Cyclosporin A, a cyclic undecapeptide produced by the fungus Tolypocladium inflatum Gams, is a powerful immunosuppressant drug [1] , which selectively inhibits the interleukin-2 (IL-2)-driven proliferation of activated T-lymphocytes. The pharmacokinetics of CyA exhibit a high inter-and intraindividual variability, which is dependent upon various factors such as food interactions, influence of bile, and physicochemical parameters, e.g., the high lipophilicity or differences in drug metabolism caused by the patient's metabolic situation [24] . The immunosuppressive therapy may be associated with adverse effects including renal dysfunction, vascular damage and hepatic side effects [5, 25] . CyAinduced increases of serum bile acid levels in animal and man [10, 12, 26] are indicative for a certain cholestatic potential. Since the data on hepatic transport of CyA are controversial [14] [15] [16] , we investigated the transport of that important drug in more detail in several in vitro models.
CyA has a unique lipophilicity making effects upon cellular membranes most likely, for example, the anisotropy decrease correlates with a dramatic increase of the membrane permeability of Na+ and Ca2+. Both effects, the changes in membrane fluidity as well as in ion homeostasis, may contribute to the decrease of hepatic bile acid uptake during CyA trealtment by disturbing the transmembrane potential and cellular ion gradients. Similar effects have also been observed in other cellular systems [27, 28] . In human lymphocytes CyA caused an enhanced K+ efflux and reduced the membrane potential. Therefore it is likely, that such alterations in membrane integrity also contribute to CyA-induced disturbances of liver function.
The increase of serum bile acid levels in patients observed during CyA-treatment indicates a disturbance of hepatic bile acid transport. In our study, CyA had a pronounced effect on taurocholate uptake with an apparently competitive type of inhibition. For the present, this confirms previous findings with rat hepatocyte basolateral plasma membranes and hepatocyte primary cultures, where a competitive inhibition was also observed [ 15, 29] . However, CyA itself showed no sign of active uptake by isolated rat hepatocytes. Therefore, we conclude that the inhibition of bile acid transport is the result of an unspecific binding, the observed disturbance in ion homeostasis, and a simple rapid partitioning into the lipid phase. The present finding is supported by findings in isolated intact kidney tubules, where a passive uptake of cylcosporins from the basolateral side and an active secretion at the luminal side was observed [30] .
Previous studies indicated that CyA is a potent inhibitor of ATP-dependent transport processes at the canalicular membrane including p-glycoprotein mediated transport [31] [32] [33] [34] . Here, we demonstrate that CyA itself can be transported across bile canalicular membranes by an active, ATP-dependent mechanism. The photoaffinity labeling experiment and the kinetic experiment give clear evidence that it is a substrate for p-glycoprotein. The labeling was decreased in the presence unlabeled CyA and of the p-glycoprotein substrate PSC-833, which is a non-immunosuppressive cyclosporin derivative with a very high affinity to p-glycoprotein [35] [36] [37] . Our findings are in accordance with kinetic and photoaffinity labeling experiments in kidney tubular cells [30, 38, 39] , kinetic studies with the intestinal cell line Caco-2 [40] and at the brain capillary endothelium [41] , all cell types expressing p-glycoprotein and exhibiting active CyA transport at their luminal side. The fact, that the initial rates of bile acid transport by the canalicular membrane vesicles remain unchanged over the first 2.5 min, suggests that CyA transport results rather in a faster use of the cellular ATP pool than in a direct competition of the drug at the bile acid carrier.
SUMMARY
The present studies indicate that CyA enters hepatocytes by passive diffusion and is secreted by p-glycoprotein. Inhibition of bile salt transport does not occur due to a specific interaction. For an estimation of the clinical relevance of these findings, the pharmacokinetic properties of CyA should be verified in primate or human studies with emphasis on the p-glycoprotein interaction of the drug.
